Abstract LB354: A novel oncolytic vaccinia virus with intravenous compatibility evaded complement- and neutralizing antibody-mediated inhibition and provided superior anti-tumor activity to intra-tumoral administration in immunocompetent mice

作者
Yeonsoo Yang,Solchan Won,Namhee Lee,Eun-Hye Kim,Songyi Lee,Mi-Ju Park,Byung-Jin Jung,Yun-Kyoung Hong,Hang‐Rae Kim,Dong‐Sup Lee,Keunhee Oh
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (7_Supplement): LB354-LB354
标识
DOI:10.1158/1538-7445.am2024-lb354
摘要

Abstract Oncolytic viruses (OVs) are potent cancer therapeutics that can selectively kill tumor cells and promote anti-tumor immunity. mSJ-650 (Wyeth, K2L-, TK-, murine GM-CSF, human CD55) is the Wyeth strain of vaccinia virus with human complement regulatory protein CD55 incorporated on the intracellular mature virion membrane to evade complement-mediated attack during circulation. The virus also expresses mGM-CSF in replace of thymidine kinase to increase tumor selectivity and enhance immunogenicity. We previously reported that a single dose of mSJ-650 effectively evades complement and shows prominent anti-tumor efficacy in A549 and HCT116 xenograft model. Here, we further investigated the capability of mSJ-650 in promoting anti-tumor response after multiple systemic administration in immunocompetent breast cancer mouse model. In an orthotopic EMT6 breast cancer model, mSJ-650 or control mSJ-612 devoid of CD55 was intravenously injected at low dose (1x106 pfu) and high dose (3x106 pfu), twice weekly. mSJ-650 treatment dose-dependently suppressed tumor growth, showing superior antitumor efficacy compared to treatment of control mSJ-612. Moreover, multiple systemic administration of mSJ-650 was well-tolerated with no apparent signs of toxicity in serum tested via AST and ALT assay. To further elucidate whether mSJ-650 can evade neutralization by antibody and maintain its antitumor potency in vivo, we designed two experimental models. Firstly, endogenous vaccinia virus specific neutralizing antibody was generated by intravenous injection of mSJ-650 prior to tumor cell inoculation in tumor-bearing mouse, followed by systemic administration of mSJ-650 twice weekly. Second, serum containing vaccinia virus specific neutralizing antibody was intravenously injected 24 hours prior to mSJ-650 administration in tumor-bearing mouse. In both experimental models, mSJ-650 treated group significantly inhibited tumor growth despite the presence of neutralizing antibody, while control mSJ-612 treated group failed to suppress tumor growth. These results imply that mSJ-650 is capable of evading neutralization and maintaining its antitumor efficacy. Moreover, we performed multi-color flow cytometry analysis of tumor-infiltrating leukocytes to evaluate immunogenicity of mSJ-650. As a result, we observed a significant increase in recruitment of activated CD4+ and CD8+ T cells by 2-fold and high expression level of cytotoxic molecules (perforin, TNF-α, IFN-γ) in tumor-infiltrating T cells. In summary, multiple systemic administration of mSJ-650 markedly evaded neutralization and suppressed tumor growth by promoting anti-tumor response in immunocompetent breast cancer mouse model, thus implying that mSJ-650 is a promising candidate for cancer immunotherapy. Citation Format: Yeonsoo Yang, Solchan Won, Namhee Lee, Eunhye Kim, Songyi Lee, Mi-Ju Park, Byung-Jin Jung, Yun-Kyoung Hong, Hang-Rae Kim, Dong-Sup Lee, Keunhee Oh. A novel oncolytic vaccinia virus with intravenous compatibility evaded complement- and neutralizing antibody-mediated inhibition and provided superior anti-tumor activity to intra-tumoral administration in immunocompetent mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr LB354.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
神经蛙完成签到,获得积分10
2秒前
淡然白萱完成签到,获得积分10
2秒前
晨风完成签到,获得积分10
5秒前
5秒前
祁嘉完成签到,获得积分0
5秒前
詹国丹完成签到 ,获得积分10
5秒前
YYYYYYY发布了新的文献求助10
5秒前
6秒前
6秒前
孤独宝马完成签到 ,获得积分10
7秒前
88完成签到,获得积分10
7秒前
Dreamer0422完成签到,获得积分10
7秒前
不可思议的西红柿完成签到,获得积分10
8秒前
jiaozitop完成签到,获得积分10
8秒前
linaoctcn发布了新的文献求助10
8秒前
科研中完成签到,获得积分10
8秒前
田様的应助被小马叽里咕噜采纳,获得10
9秒前
善良语雪发布了新的文献求助10
10秒前
liuguohua126完成签到,获得积分10
11秒前
dinhogj完成签到,获得积分10
12秒前
wcc完成签到 ,获得积分20
12秒前
章冻串完成签到,获得积分10
13秒前
chew发布了新的文献求助10
13秒前
xurui_s完成签到 ,获得积分10
13秒前
xuexue321完成签到 ,获得积分10
14秒前
14秒前
田様的应助被先锋老刘001采纳,获得10
14秒前
桐桐的应助被晓晓采纳,获得30
14秒前
梁平完成签到 ,获得积分10
14秒前
悦己发布了新的文献求助10
15秒前
16秒前
16秒前
靓丽懿轩完成签到,获得积分10
17秒前
寒冷丹雪完成签到,获得积分0
17秒前
18秒前
18秒前
小蛇完成签到,获得积分10
18秒前
18秒前
可爱的函函的应助被峰峰采纳,获得100
18秒前
所所的应助被跳跃文轩采纳,获得30
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054